SABCS: Debu Tripathy Discusses Immunotherapy in Breast Cancer
Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.
Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.
Several studies were presented that examined how immunotherapy, such as Keytruda (pembrolizumab) in triple-negative breast cancer, could provide benefit to different groups of patients.
"We look forward to the field of immunology much more and expect to see more progress, although it's not going to be dramatic, one big fell swoop at a time," he says. "We're going to make step-wise improvements in this area as we learn more about the immunology pathways as they pertain to breast cancer."
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen
Teddi Mellencamp Reveals More Melanoma Lesions, Michael Strahan’s Daughter Cancer-Free and More
July 19th 2024From Teddi Mellencamp revealing that she had more melanoma spots removed to Isabella Strahan announcing being cancer-free, here’s what’s happening in the oncology space this week.
Read More
